Skip to main content
Premium Trial:

Request an Annual Quote

Exact Sciences Signs Cologuard Coverage Contract with Anthem Blue Cross Blue Shield

NEW YORK (GenomeWeb) – Exact Sciences said today that it has signed an in-network coverage contract for the Cologuard colon cancer screening test with Anthem Blue Cross Blue Shield.

Patients covered by the insurance company in Indiana, Ohio, Kentucky, Missouri, and Wisconsin will now have access to the test as an in-network service.

"As Cologuard's in-network status grows in 2016, more people gain access to this innovative screening test. This access gives us more opportunities to find cancer in its earliest, most treatable stages," said Exact Chairman and CEO Kevin Conroy in a statement. "The momentum continues to build for Cologuard's commercial coverage and contracting. Along with more patients gaining in-network access to our test, the execution of our sales strategy and our consumer marketing efforts continue to drive Cologuard awareness among both patients and physicians."

In February, Exact announced it had signed a similar in-network coverage contract for Cologuard with Anthem Blue Cross Blue Shield in Georgia and Virginia. The test is also covered by Blue Cross Blue Shield in North Carolina, however Exact has filed a lawsuit in the United States District Court for the Middle District of North Carolina for "improperly and illegally adopt[ing] an official policy of denying benefits and refusing to pay Exact" for the costs of performing Cologuard.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.